Thrombolytics and mortality in PE

In this statewide database analysis of inpatients with PE, 2.4% of patients received thrombolytics. After propensity adjustment, the patients in the lowest propensity category had a higher risk of mortality with thrombolytics, but the patients in the highest propensity category had a lower risk of mortality with thrombolytics. Based on this and other studies, thrombolytics should be used only in the highest risk PE patients (abstract).

Danielle Scheurer

Dr. Scheurer is a clinical hospitalist and the Medical Director of Quality and Safety at the Medical University of South Carolina in Charleston, South Carolina, and is Assistant Professor of Medicine. She is a graduate of the University of Tennessee College of Medicine, completed her residency at Duke University, and completed her Masters in Clinical Research at the Medical University of South Carolina. She also serves as the Web Editor and Physician Advisor for the Society of Hospital Medicine.

Leave a Comment